Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBiocon

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • See more upside in Biocon, says Sukhani

      See more upside in Biocon, says Sudarshan Sukhani of s2analytics.com.

    • Buy Biocon, says Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Biocon.

    • Hold Biocon, says Anu Jain

      Hold Biocon, says Anu Jain of IIFL Private Wealth Management.

    • Super Six trading ideas for June 22

      On CNBC-TV18's show Super Six, market gurus Vishal B Malkan, CMT, www.malkansview.com, Vishal Kshatriya of Edelweiss and Sanjeev Agarwal, CEO, Dynamix Research & Capital Management, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Buy Biocon, says D D Sharma

      D D Sharma of Risk Capital Advisors is of the view that one should buy Biocon.

    • Biocon has target of Rs 228-225: Sukhani

      Biocon has target of Rs 228-225, says Sudarshan Sukhani of s2analytics.com.

    • Buy Biocon above Rs 245: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that above Rs 245, Biocon will be an excellent buying opportunity.

    • Biocon has target of Rs 300: SP Tulsian

      Biocon has target of Rs 300, says SP Tulsian, sptulsian.com.

    • Buying opportunity seen in Biocon: SP Tulsian

      Buying opportunity is seen in Biocon, says SP Tulsian, sptulsian.com.

    • Sell Biocon on rally: Amit Harchekar

      Sell Biocon on rally, says Amit Harchekar, Sr Technical Analyst –CMT at IIFL India Private Ltd.

    • Stay away from Biocon: PN Vijay

      PN Vijay, Portfolio Manager advices to stay away from Biocon.

    • Super Six stocks you can bet on Feb 27

      On CNBC-TV18's show Super Six, market gurus Vishal B Malkan, CMT, www.malkansview.com, Vishal Kshatriya, Sr Derivative and Technical Analyst, Edelweiss and Rakesh Gandhi, Sr Technical Analyst, LKP, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Biocon has target of Rs 296: Amit Gupta

      Biocon has target of Rs 296, says Amit Gupta, Head-Derivatives -ICICI Direct.

    • Enter Biocon, says Hemant Thukral

      Enter Biocon, says Hemant Thukral, National Head-Derivative Desk, Aditya Birla Money.

    • Buy Biocon, says Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Biocon.

    • 6 stock ideas to liven up your trade

      On CNBC-TV18's new show Super Six, market gurus Hemen Kapadia of chartpundit.com, Nooresh Merani of AMSEC Research and Arunesh Madan, Founder and Director of Augment Investment Pvt ltd, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • See more upside in Idea: Sukhani

      Sudarshan Sukhani, s2analytics.com feels that there is more upside in Idea.

    • Short Biocon: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com one can short Biocon.

    • Axis Bank may slip to Rs 787 levels: Manghnani

      Axis Bank may slip to Rs 787 levels, says Anil Manghnani, Modern Shares & Stock Brokers.

    • Orchid Chemicals, Biocon may see limited downside: Tulsian

      Orchid Chemicals and Biocon may see limited downside, says SP Tulsian of sptulsian.com.

    • Bull's Eye: Buy Biocon, Bata; short HCL Tech, Yes Bank

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Hindustan Zinc can move to Rs 135-137: Sukhani

      Hindustan Zinc can move to Rs 135-137, says Sudarshan Sukhani, s2analytics.com.

    • Buy Biocon around Rs 320- 321: Gupta

      Buy Biocon around Rs 320- 321, says Amit Gupta of ICICI Direct.

    • Check Out: Super Six stocks for Novemver 23

      On CNBC-TV18's new show Super Six, market gurus Manas Jaiswal, Technical Analyst of Emkay Global, Nooresh Mirani, Head, AMSEC-Analyse India and Parag Doctor of Motilal Oswal Securitiest, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Sanjay Vaid's view Biocon

      Sanjay Vaid of SBI Capital share his view on Biocon.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347